Defining the Communication Between Agonist and Coactivator Binding in the Retinoid X Receptor a Ligand Binding Domain
News Nov 06, 2013
Background: Some retinoid X receptor (RXR) agonists have potential as cancer drugs.
Results: Structures of RXR in complex with two different agonists show similar folds. Dynamics analysis reveals unique ligand-induced dynamics in helices 3, 11, and 12.
Conclusion: Two networks of interactions which connect RXR agonists to coactivator binding are defined.
Significance: Recognizing common conformational changes and distinguishing dynamics of RXR-selective agonists is needed for advances in drug design.
This article was published online in The Journal of Biological Chemistry and is free to access.
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE
Pain's Origins May Be Significantly Different in Males and FemalesNews
Researchers found that a specific manipulation of receptors in the nervous system for the neurotransmitter dopamine impairs chronic pain in male mice, but has no effect on females.READ MORE